AR058283A1 - Metodos para la preparacion de rapamicina cristalina y para la medicion de la cristalinidad de los compuestos de rapamicina utilizando calorimetria diferencial de barrido - Google Patents

Metodos para la preparacion de rapamicina cristalina y para la medicion de la cristalinidad de los compuestos de rapamicina utilizando calorimetria diferencial de barrido

Info

Publication number
AR058283A1
AR058283A1 ARP060105389A ARP060105389A AR058283A1 AR 058283 A1 AR058283 A1 AR 058283A1 AR P060105389 A ARP060105389 A AR P060105389A AR P060105389 A ARP060105389 A AR P060105389A AR 058283 A1 AR058283 A1 AR 058283A1
Authority
AR
Argentina
Prior art keywords
rapamycin
methods
calorimetry
differential
barrido
Prior art date
Application number
ARP060105389A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR058283A1 publication Critical patent/AR058283A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N25/00—Investigating or analyzing materials by the use of thermal means
    • G01N25/20—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N25/00—Investigating or analyzing materials by the use of thermal means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N25/00—Investigating or analyzing materials by the use of thermal means
    • G01N25/20—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity
    • G01N25/48—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation
    • G01N25/4846—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation for a motionless, e.g. solid sample
    • G01N25/4866—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation for a motionless, e.g. solid sample by using a differential method

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Combustion & Propulsion (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analyzing Materials Using Thermal Means (AREA)

Abstract

También se dan a conocer métodos para medir la cristalinidad de muestras con contenido de rapamicina o un derivado de la misma. Reivindicacion 1: Un método para medir la calidad de partícula de un compuesto de rapamicina utilizando calorimetría diferencial de barrido, que comprende el análisis de la senal de flujo de calor de una muestra que contiene un compuesto de rapamicina y la comparacion de la senal de flujo de calor de dicha muestra con la senal de flujo de calor de un standard predeterminado, donde dicha calidad de las partículas es proporcional a la temperatura de fusion de dicha senal de flujo de calor de dicha muestra.
ARP060105389A 2005-12-07 2006-12-06 Metodos para la preparacion de rapamicina cristalina y para la medicion de la cristalinidad de los compuestos de rapamicina utilizando calorimetria diferencial de barrido AR058283A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74800505P 2005-12-07 2005-12-07

Publications (1)

Publication Number Publication Date
AR058283A1 true AR058283A1 (es) 2008-01-30

Family

ID=38117222

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060105389A AR058283A1 (es) 2005-12-07 2006-12-06 Metodos para la preparacion de rapamicina cristalina y para la medicion de la cristalinidad de los compuestos de rapamicina utilizando calorimetria diferencial de barrido

Country Status (17)

Country Link
US (1) US20070128731A1 (es)
EP (1) EP1957964A2 (es)
JP (1) JP2009518648A (es)
KR (1) KR20080077147A (es)
CN (1) CN101351702A (es)
AR (1) AR058283A1 (es)
AU (1) AU2006322030A1 (es)
BR (1) BRPI0619592A2 (es)
CA (1) CA2630786A1 (es)
CR (1) CR9985A (es)
EC (1) ECSP088519A (es)
IL (1) IL191545A0 (es)
NO (1) NO20082382L (es)
PE (1) PE20071000A1 (es)
RU (1) RU2008120712A (es)
TW (1) TW200736603A (es)
WO (1) WO2007067566A2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010084501A1 (en) * 2009-01-21 2010-07-29 Biocon Limited A method for determination of sirolimus stability and process for preparing its stable form
FR2943539B1 (fr) 2009-03-31 2011-07-22 Ethypharm Sa Composition pharmaceutique comprenant un macrolide immunosuppresseur de la famille des limus.
US20140297202A1 (en) * 2011-08-05 2014-10-02 Apple Inc. Nondestructive method to determine crystallinity in amorphous alloy
WO2013162501A1 (en) * 2012-04-23 2013-10-31 Apple Inc. Non-destructive determination of volumetric crystallinity of bulk amorphous alloy
SG11201507406YA (en) 2013-03-15 2015-10-29 Biosensors Int Group Ltd Purification of rapamycin derivatives
US9439892B2 (en) 2013-05-16 2016-09-13 Surmodics, Inc. Macrolide particulates, methods for preparation, and medical devices associated therewith
WO2014201236A1 (en) * 2013-06-12 2014-12-18 Surmodics, Inc. Solvent methods for preparing crystalline macrolide particulates, compositions, and articles containing particulates
DE102013110294B4 (de) * 2013-09-18 2016-07-07 Innora Gmbh Limus-Depot-Formulierung auf Ballonkathetern
WO2015181826A1 (en) 2014-05-27 2015-12-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Crystalline coating and release of bioactive agents
CN105116013A (zh) * 2015-04-23 2015-12-02 山东农业大学 一种确定金属离子对蛋白酶水解大豆分离蛋白影响的方法
JP6531488B2 (ja) * 2015-05-22 2019-06-19 日産自動車株式会社 リチウムイオン二次電池の熱履歴検知方法
EP3435988B1 (en) 2016-03-31 2021-10-06 Surmodics, Inc. Drug-containing particulate composition with cationic agent, associated medical devices, and methods for treatment
WO2018112196A1 (en) 2016-12-16 2018-06-21 Surmodics, Inc. Hydrophobic active agent particle coatings and methods for treatment
US11629222B2 (en) * 2019-07-01 2023-04-18 Ethicon, Inc. Calorimetric crystallization method for evaluation of monomer purity
NL2031004B1 (en) * 2022-02-18 2023-09-05 Univ Delft Tech Novel method for analyzing DSC data
WO2023158308A1 (en) 2022-02-18 2023-08-24 Technische Universiteit Delft Novel method for analyzing dsc data

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA737247B (en) * 1972-09-29 1975-04-30 Ayerst Mckenna & Harrison Rapamycin and process of preparation
US5358909A (en) * 1991-02-27 1994-10-25 Nippon Steel Corporation Method of manufacturing field-emitter
US5358908A (en) * 1992-02-14 1994-10-25 Micron Technology, Inc. Method of creating sharp points and other features on the surface of a semiconductor substrate
GB9313650D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
US5385909A (en) * 1993-11-22 1995-01-31 American Home Products Corporation Heterocyclic esters of rapamycin
US5385908A (en) * 1993-11-22 1995-01-31 American Home Products Corporation Hindered esters of rapamycin
US5362718A (en) * 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
EP0884585A3 (de) * 1997-06-06 1999-12-29 Netzsch Gerätebau GmbH Vorrichtung zur Differential-Scanning-Kalorimetrie
GB9826882D0 (en) * 1998-12-07 1999-01-27 Novartis Ag Organic compounds
US6277983B1 (en) * 2000-09-27 2001-08-21 American Home Products Corporation Regioselective synthesis of rapamycin derivatives
ES2177373B1 (es) * 1999-11-26 2003-11-01 Astur Pharma Sa Preparacion de azitromicina en su forma no cristalina
JP2004509898A (ja) * 2000-09-19 2004-04-02 ワイス 水溶性ラパマイシンエステル
US20040187770A1 (en) * 2001-10-17 2004-09-30 Calabrese Richard V. Rotor-stator apparatus and process for the formation of particles
US20060169199A1 (en) * 2003-03-31 2006-08-03 Vilmos Keri Crystallization and purification of macrolides
US7220357B2 (en) * 2003-07-24 2007-05-22 Teva Gyógyszergyár Zártkörúen Múkó´dó´Résvénytársaság Method of purifying macrolides
DK1658295T3 (da) * 2003-08-07 2007-09-24 Wyeth Corp Regioselektiv syntese af CCI-779
CN1874771A (zh) * 2003-09-03 2006-12-06 惠氏公司 3－羟基－2－(羟甲基)－2－甲基丙酸的非晶态雷帕霉素42－酯及其包含相同化合物的药用组合物
CA2562952A1 (en) * 2004-04-14 2005-11-10 Wyeth Regiospecific synthesis of rapamycin 42-ester derivatives
AU2005238432A1 (en) * 2004-04-14 2005-11-10 Wyeth Process for preparing rapamycin 42-esters and FK-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies
PA8641501A1 (es) * 2004-08-10 2006-09-08 Wyeth Corp Derivados de cci-779 y metodo para su preparacion
CN101084226A (zh) * 2004-12-20 2007-12-05 惠氏公司 雷帕霉素衍生物及其治疗神经紊乱的用途
ES2380779T3 (es) * 2004-12-20 2012-05-18 Wyeth Llc Análogos de rapamicina y usos de los mismos en el tratamiento de trastornos neurológicos, proliferativos e inflamatorios
AU2006213061A1 (en) * 2005-02-09 2006-08-17 Wyeth CCI-779 polymorph and use thereof
EP1853611A1 (en) * 2005-03-02 2007-11-14 Wyeth Recovery of cci-779 from mother liquors
JP2008533007A (ja) * 2005-03-07 2008-08-21 ワイス ４２−ｏ−（２−ヒドロキシ）エチル−ラパマイシンのオキセパン異性体

Also Published As

Publication number Publication date
PE20071000A1 (es) 2007-10-10
WO2007067566A3 (en) 2008-01-24
AU2006322030A1 (en) 2007-06-14
JP2009518648A (ja) 2009-05-07
CN101351702A (zh) 2009-01-21
IL191545A0 (en) 2008-12-29
RU2008120712A (ru) 2010-01-20
TW200736603A (en) 2007-10-01
BRPI0619592A2 (pt) 2016-09-06
EP1957964A2 (en) 2008-08-20
CR9985A (es) 2008-08-21
CA2630786A1 (en) 2007-06-14
KR20080077147A (ko) 2008-08-21
WO2007067566A2 (en) 2007-06-14
US20070128731A1 (en) 2007-06-07
NO20082382L (no) 2008-09-04
ECSP088519A (es) 2008-07-30

Similar Documents

Publication Publication Date Title
AR058283A1 (es) Metodos para la preparacion de rapamicina cristalina y para la medicion de la cristalinidad de los compuestos de rapamicina utilizando calorimetria diferencial de barrido
Gong et al. A fluorescence enhancement probe based on BODIPY for the discrimination of cysteine from homocysteine and glutathione
Liu et al. Construction of NIR and ratiometric fluorescent probe for Hg 2+ based on a rhodamine-inspired dye platform
Kong et al. Engineering an AIE N2H4 fluorescent probe based on α-cyanostilbene derivative with large Stokes shift and its versatile applications in solution, solid-state and biological systems
US20130125674A1 (en) Sample chamber for laser ablation analysis of fluid inclusions and analyzing device thereof
Liang et al. Determination of thiol by high-performance liquid chromatography and fluorescence detection with 5-methyl-(2-(m-iodoacetylaminophenyl) benzoxazole
US10921327B2 (en) Probes for quantitative imaging of thiols in various environments
CN104193666B (zh) 一种1,3‑二取代马来酰亚胺化合物及其作为表面活性剂临界胶束浓度荧光探针的应用
Niu et al. A novel colorimetric and ratiometric fluorescent probe for sensing SO 2 derivatives and their bio-imaging in living cells
Briddon et al. Design and use of fluorescent ligands to study ligand–receptor interactions in single living cells
WO2006047662A3 (en) Method and apparatus for sediment characterization
Stafforst et al. Kinetic characterization of spiropyrans in aqueous media
Zhang et al. Continuous underway measurements of dimethyl sulfide in seawater by purge and trap gas chromatography coupled with pulsed flame photometric detection
Zhu et al. Multi‐Fluorinated Azido Coumarins for Rapid and Selective Detection of Biological H2S in Living Cells
Yan et al. A rhodamine based fluorescent probe for Hg2+ and its application to cellular imaging
CN108658838A (zh) 一种基于七甲川吲哚菁的甲醛荧光探针及其制备方法和使用方法
Li et al. Novel 2-benzo [d] thiazolyl-4-quinolinylphenol skeleton-based turn-on fluorescent probe for H2S detection and its multiple applications in water environment, foodstuffs, and living organisms
BRPI0413061A (pt) dispositivo para a detecção e caracterização de tecido biológico
Jaworska et al. Evaluation of the potential of surface enhancement Raman spectroscopy for detection of tricyclic psychotropic drugs. Case studies on imipramine and its metabolite
WO2006115601A3 (en) Nanoliter osmometer and method of operation
Bachilo et al. Time-resolved thermally activated delayed fluorescence in C70 and 1, 2-C70H2
WO2008092895A3 (de) Vorrichtung und verfahren zur bestimmung der stoffmenge in kleinen kavitäten
Wu et al. A convenient method for determination of quizalofop-p-ethyl based on the fluorescence quenching of eosin Y in the presence of Pd (II)
Gibner et al. Rapid heating in high-temperature thermomicroscopic analysis
Wang et al. A colorimetric sensor for pH utilizing a quinoline derivative

Legal Events

Date Code Title Description
FB Suspension of granting procedure